Mucinex 12 Hour Expectorant, OTC Medicine for Excess Mucus Relief, Chest Congestion, FSA, 20 Tablets

Are you searching for reliable chest congestion relief for adults? Look no further than Mucinex 12 Hour Expectorant for excess mucus relief. Featuring a robust 600mg of guaifenesin, this top-notch expectorant thins and loosens mucus thereby making coughs more productive. When the cold and flu season hits, trust Mucinex for powerful chest congestion relief. Our original bi-layer tablet provides immediate and extended-release and lasts up to 12 hours. Use as directed, for Adults and Children 12 years of age and over. EXCESS MUCUS RELIEF: Mucinex 12hr extended-release tablets pack a powerful punch with 600 mg guaifenesin expectorant, providing you with long-lasting chest congestion relief AIDS EXCESS MUCUS REMOVAL: Mucinex SE lasts up to 12 hours, provides chest congestion relief and makes coughs more productive EXPECTORANTS FOR ADULTS: Mucinex helps clear lungs by thinning & loosening mucus; Say goodbye to excess mucus, say hello to chest congestion relief EXTENDED RELEASE GUAIFENESIN: Experience long-lasting excess mucus relief with Mucinex's 12hr extended-release 600mg guaifenesin tablets; our original bi-layer tablets have both immediate & extended release TRUSTED BRAND: Mucinex is the #1 Cough & Cold Brand Doctor's Trust* and is also the #1 Pharmacist Recommended OTC Expectorant**; Get the brand that doctors trust and recommend COLD AND FLU MEDICINE FOR ADULTS: For powerful cough, cold, and flu multi-symptom relief, check out our range of Mucinex Fast-Max cold and flu medicines; Beat cold and flu symptoms with confidence USAGE: Use as directed; For ages 12+ years FSA & HSA Eligible: Save Up to 30% - Cover out-of-pocket expenses with pre-tax dollars (Product eligibility may vary by plan; Check with your benefits administrator to determine which expenses are eligible before you shop) QUALITY YOU CAN TRUST: Mucinex uses carbomer that is manufactured without the use of benzene *IQVIA using ProVoice Survey, August 2023; **U.S. News & World Report/Pharmacy Times 2023-2024